|
Objective 1:
| State “eras” of HF therapies prior to the personalized era and provide 1 example of a therapy used during each era |
|
Objective 2:
| Describe what the personalized era of HF therapies means in relation to variability of drug efficacy and newer ways of assessing patient response to drug therapies |
|
Objective 3:
| Describe what the personalized era of HF therapies means based on emerging drug and devices in clinical trials |
